DCC-3084

DCC-3084 · Deciphera Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCC-3084, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway [Phase 1]

See pricing